Defence Therapeutics' pipeline offers market potential in the range of several hundred billion USD. We present the six most important projects and explain why 2023 will be crunch time for Defence Therapeutics - the decisive phase for the Company and its shareholders is just around the corner. As Defence continues to write its success stories, the multifaceted Canadian company could soon be wooed by pharmaceutical giants - the first collaborations have already been signed.Den vollständigen Artikel lesen ...
© 2023 researchanalyst.com (EN)